000 01307 a2200349 4500
005 20250516160847.0
264 0 _c20140317
008 201403s 0 0 eng d
022 _a1573-742X
024 7 _a10.1007/s11239-013-0955-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGalanis, Taki
245 0 0 _aNew oral anticoagulants: prevention of VTE in phase III studies in total joint replacement surgery and the hospitalized medically-ill patients.
_h[electronic resource]
260 _bJournal of thrombosis and thrombolysis
_cAug 2013
300 _a141-8 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnticoagulants
_xadverse effects
650 0 4 _aArthroplasty, Replacement
650 0 4 _aClinical Trials, Phase III as Topic
650 0 4 _aFactor Xa Inhibitors
650 0 4 _aFemale
650 0 4 _aHospitalization
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMonitoring, Physiologic
_xmethods
650 0 4 _aThrombin
_xantagonists & inhibitors
650 0 4 _aUnited States
650 0 4 _aVenous Thromboembolism
_xepidemiology
700 1 _aMerli, Geno J
773 0 _tJournal of thrombosis and thrombolysis
_gvol. 36
_gno. 2
_gp. 141-8
856 4 0 _uhttps://doi.org/10.1007/s11239-013-0955-3
_zAvailable from publisher's website
999 _c22910925
_d22910925